首页> 外国专利> CAR T CELLS TARGETING THE INTEGRIN ALPHAv BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES

CAR T CELLS TARGETING THE INTEGRIN ALPHAv BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES

机译:靶向整合蛋白α3的汽车T细胞表现出对胶质瘤和其他实体肿瘤恶性肿瘤的强大抗肿瘤反应

摘要

Methods and compositions for treating cancer, including brain cancers such as diffuse intrinsic pontine glioma (DIPG) and glioblastoma (GBM), breast cancers, melanomas, cervical cancers, bladder cancers, lung cancers, neuroblastomas, and rhabdomyosarcomas (RMS), are described. Also described are methods of preparing cells comprising chimeric antigen receptors (CARs), such as CAR T cells, that target integrin alphav beta3 (ανβ3).
机译:描述了治疗癌症的方法和组合物,包括脑癌,如弥漫性内在猪胶质瘤(DIPG)和胶质母细胞瘤(GBM),乳腺癌,黑色素,宫颈癌,膀胱癌,肺癌,肺癌,神经细胞瘤和横纹肌瘤(RMS)。 还描述了制备包含嵌合抗原受体(如汽车T细胞的细胞,例如Car T细胞的细胞,该细胞蛋白αavavβ3(ανβ3)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号